Covidien buys Power Medical Interventions
This article was originally published in The Gray Sheet
Executive Summary
Firm will acquire Power Medical Interventions, maker of computer-assisted surgical cutting and stapling products, for about $64 million including debt, in an all-cash tender offer. The Langhorne, Pa.-based firm had 2008 revenues of $9 million. PMI's products include the SurgAssist power stapler and wireless Intelligent Surgical Instruments, such as the firm's i60 articulating endoscopic linear cutter for laparoscopic surgery. PMI also has standing agreements with Intuitive Surgical to jointly develop a novel surgical stapling device that will attach to Intuitive's da Vinci surgical system. Covidien said in a July 30 third-quarter earnings call it will honor those agreements and "look[s] forward to working with Intuitive." PMI's stock price rose 250% from $0.58 to $2.03 following the July 29 announcement. The deal is expected to close by Sept. 25. A Covidien subsidiary will pay $2.08 per share for PMI's common stock
You may also be interested in...
Covidien Gains BIS Anesthesia Monitoring Technology In Aspect Medical Buy
Covidien is adding brain monitoring technology to its lineup through the $210 million acquisition of Aspect Medical Systems, announced Sept. 28
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.